You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Aveanna Healthcare Holdings Inc. reported Q3 2026 revenue of $695.5 million, up 11.8%, gross margin of 32.6% and Adjusted EBITDA of $100.1 million. YTD free cash flow reached $141.2 million, and liquidity totaled $492.1 million.
On October 1, 2026, Steven E. Rodgers resigned effective immediately from Aveanna Healthcare Holdings Inc.’s Board of Directors, citing no disagreement with the company over its operations, policies, or practices; he served on the Audit and Compensation Committees.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $179.8M | Six-Month Periods Ended July 4, 2026 | — |
|
|
|||
| Adjusted net income per diluted share non-GAAP | $0.4 | Six-Month Periods Ended July 4, 2026 | — |
|
|
|||
| Cost of revenue rate | $31.9 | Six-month period ended July 4, 2026 | — |
| Cost of revenue rate (MS) | $274.46 | Q2 FY2026 | — |
| Field contribution non-GAAP | $231.08M | Six-month period ended July 4, 2026 | — |
| Field contribution margin | 17.5% | six-month period ended July 4, 2026 | — |
| Free cash flow non-GAAP | $75.4M | Six-Month Periods Ended July 4, 2026 | — |
| Home health episodic admissions | 17.4K | Six-month period ended July 4, 2026 | — |
| Home health episodic mix | 80.9% | Six-month period ended July 4, 2026 | — |
| Home health revenue per completed episode | $3,185 | Six-month period ended July 4, 2026 | — |
| Home health total admissions | 21.5K | Six-month period ended July 4, 2026 | — |
| Home health total episodes | 29.6K | Six-month period ended July 4, 2026 | — |
| Hours | 24.47M | Six-month period ended July 4, 2026 | — |
| Revenue rate | $44.53 | Six-month period ended July 4, 2026 | — |
| Revenue rate (MS) | $500.33 | Q2 FY2026 | — |
| Spread rate | $12.63 | Six-month period ended July 4, 2026 | — |
| Spread rate (MS) | $225.87 | Q2 FY2026 | — |
| Unique patients served ("UPS") | 188K | six-month period ended July 4, 2026 | — |
|
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AVAH
this stock
Aveanna Healthcare Holdings, Inc.
|
$2.51B | +40.8% | +20.2% | 8.2 | 3.3% |
|
HCA
HCA Healthcare, Inc.
|
$104.25B | +6.9% | +7.1% | 16.6 | 2.3% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$33.34B | +3.3% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$22.76B | +43.9% | +0.9% | 8.3 | 2.2% |
|
EHC
Encompass Health Corp
|
$13.83B | +32.8% | +10.5% | 22.0 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Aveanna Healthcare Holdings Inc. reported Q3 2026 revenue of $695.5 million, up 11.8%, gross margin of 32.6% and Adjusted EBITDA of $100.1 million. YTD free cash flow reached $141.2 million, and liquidity totaled $492.1 million.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AVAH | -13.2% | -6.8% | +58.0% | -12.6% | +40.8% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -15.8% | -5.7% | +57.5% | -12.4% | +30.1% |
